Form 4: HealthStream CEO Boosts Stake with New Equity Awards
Insider Equity Grant
HealthStream's CEO and Chairman, Robert A. Frist Jr., reported new grants of restricted stock units and stock options, alongside his substantial existing direct and indirect holdings.
Summary
- Robert A. Frist Jr., CEO and Chairman of HealthStream Inc. (HSTM), reported changes in his beneficial ownership through new equity grants.
- He was granted 3,134 Restricted Share Units (RSUs) on December 9, 2025, which represent the contingent right to receive one share of common stock upon vesting.
- These RSUs are subject to a four-year vesting schedule, contingent upon continued service: 15% vest on December 9, 2026, 20% on December 9, 2027, 30% on December 9, 2028, and the remaining 35% vest on December 9, 2029.
- He was also granted 9,402 Employee Stock Options (right to buy) with an exercise price of $23.93 on December 9, 2025.
- These options have the same four-year vesting schedule as the RSUs and will expire on December 9, 2035.
- His direct beneficial ownership of common stock remains 4,586,470 shares.
- Indirect beneficial ownership through various trusts totals 680,000 shares, including 10,000 shares each in The Carolyn Marie Frist 2005 Vested Trust, The Cate Merriman Frist 2005 Vested Trust, and The Eleanor Knox Frist 2005 Vested Trust.
- Additional indirect holdings include 18,335 shares in Louise Trust u/a/d 08-16-2007, 18,334 shares each in Merriman Trust u/a/d 08-16-2007, Marie Trust u/a/d 08-16-2007, and Knox Trust u/a/d 08-16-2007, and 595,000 shares in Bobby and Melissa Frist Children's 2012 GST-Exempt Trust.
Sentiment
Score: 7
Explanation: The CEO received new equity awards (RSUs and stock options) which typically align management's interests with long-term shareholder value, contingent on continued service and performance. This is generally viewed as a positive for corporate governance and executive retention.
Positives
- The grant of 3,134 Restricted Share Units (RSUs) and 9,402 Employee Stock Options aligns the CEO's long-term interests with shareholder value.
- The four-year vesting schedule for both RSUs and options incentivizes continued service and performance from the CEO, promoting stability in leadership.
Risks
- The vesting of the 3,134 Restricted Share Units and 9,402 Employee Stock Options is contingent upon continued service, meaning the awards could be forfeited if the CEO leaves the company before the specified vesting dates.
Future Outlook
The grants of Restricted Share Units and Employee Stock Options are subject to a four-year vesting schedule, contingent on continued service. The vesting will occur in tranches on December 9, 2026 (15%), December 9, 2027 (20%), December 9, 2028 (30%), and December 9, 2029 (35%). The stock options will expire on December 9, 2035.
Industry Context
This Form 4 filing reports an insider transaction, specifically equity grants to a key executive. Such grants are a common practice in the healthcare technology industry to incentivize long-term performance and retain leadership, aligning executive interests with shareholder value.
Related Party Transactions
- Indirect beneficial ownership is held through several family trusts, including The Carolyn Marie Frist 2005 Vested Trust, The Cate Merriman Frist 2005 Vested Trust, The Eleanor Knox Frist 2005 Vested Trust, Louise Trust u/a/d 08-16-2007, Merriman Trust u/a/d 08-16-2007, Marie Trust u/a/d 08-16-2007, Knox Trust u/a/d 08-16-2007, and Bobby and Melissa Frist Children's 2012 GST-Exempt Trust.
Stakeholder Impact
- Shareholders: The equity grants to the CEO are designed to align his long-term financial interests with the company's performance, potentially benefiting shareholders through sustained growth and value creation.
- Employees: The CEO's continued commitment, incentivized by these awards, can contribute to stable leadership and strategic direction for the company's workforce.
Next Steps
- Continued service of the CEO to meet vesting conditions for RSUs and stock options.
- Future vesting events for RSUs and stock options on December 9, 2026, 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 2005 | Establishment year for The Carolyn Marie Frist, The Cate Merriman Frist, and The Eleanor Knox Frist Vested Trusts. |
| 2007-08-16 | Date of trust agreement for Louise, Merriman, Marie, and Knox Trusts. |
| 2012 | Establishment year for Bobby and Melissa Frist Children's 2012 GST-Exempt Trust. |
| 2025-12-09 | Date of grant for 3,134 Restricted Share Units and 9,402 Employee Stock Options. |
| 2025-12-11 | Date the Form 4 was signed and filed by Robert A. Frist Jr. |
| 2026-12-09 | First vesting date for 15% of RSUs and Employee Stock Options. |
| 2027-12-09 | Second vesting date for 20% of RSUs and Employee Stock Options. |
| 2028-12-09 | Third vesting date for 30% of RSUs and Employee Stock Options. |
| 2029-12-09 | Final vesting date for 35% of RSUs and Employee Stock Options. |
| 2035-12-09 | Expiration date for the Employee Stock Options. |
Keywords
HSTM, HealthStream, Form 4, Insider Transaction, Equity Grant, Restricted Share Units, Stock Options, Beneficial Ownership, CEO, Chairman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.